Top Story

Oncologists criticize high drug costs, propose cost-cutting measures

July 28, 2015

Over 100 U.S. oncologists have issued a statement deriding the high cost of cancer drugs and calling for new regulations to mitigate expenses.

Authors of the statement — published in Mayo Clinic Proceedings — recommended the creation of a post-FDA approval price review process and the importation of foreign cancer drugs for personal use, among other suggestions.

Brennan Spiegel, MD In the Journals

Latinos, blacks with family history of CRC less likely to receive colonoscopy than whites

July 28, 2015
Among individuals with a family history of colorectal cancer, Latinos and blacks were less likely to undergo guideline-recommended screening colonoscopy compared with…
FDA News

FDA grants breakthrough therapy designation to Azedra for pheochromocytoma, paraganglioma

July 28, 2015
The FDA granted breakthrough therapy designation to Ultratrace iobenguane I-131 for the treatment of patients with iobenguane-avid metastatic or recurrent…
Takashi Nojiri In the Journals

Low-dose olprinone reduces risk for atrial fibrillation after lung cancer surgery

July 28, 2015
The administration of olprinone continuously during lung cancer surgery reduced the risk for atrial fibrillation in patients with elevated preoperative B-type…
In the Journals

Combination of cladribine, cytarabine improves survival for children with LCH

July 28, 2015
The combination of cladribine and cytarabine conferred high survival rates among children with high-risk, risk organ-positive Langerhans cell histiocytosis, according to…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »